Last updated on September 2018

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

Brief description of study

The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy discontinuation criteria in a prior Gilead-sponsored filgotinib treatment study in ulcerative colitis (UC).

Clinical Study Identifier: NCT02914535

Contact Investigators or Research Sites near you

Start Over

Gilead Clinical Study Information Center

Florida Medical Clinic, P.A.
Zephyrhills, FL United States